ValiRx plc (LON:VAL – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of GBX 0.15 and traded as high as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 159,494 shares changing hands.
ValiRx Stock Performance
The stock has a 50 day moving average of GBX 0.15 and a 200 day moving average of GBX 0.19. The stock has a market capitalization of £1.77 million, a P/E ratio of -0.33 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. On average, research analysts anticipate that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
